Clinical trial
Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage…
NCT00281840 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00281840 |
|---|---|
| Title | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | A Phase II Study of Bevacizumab in Combination With Docetaxel and Radiation in Locally Advanced Squamous Cell Cancer of the Head and Neck |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | bevacizumab, docetaxel, conventional surgery, radiation therapy |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jan 25, 2006 |
| Last update posted | Jun 9, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: